AMV564

Amphivena raises $62M Series C round to develop bispecific antibody in solid tumors

The company presented data from a Phase I study in acute myeloid leukemia at the European Hematology Association's annual meeting during the summer.

By Alaric DeArment

The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions

In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.

By Impact Brands

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

By PurpleLab